Dr John Campbell
@campbellteaching·3.3M subscribers·3.1K videos
NIH and ivermectin
Posted
October 18, 2021
Views
327,056
Likes
11,208
Comments
5,417
Engagement
5.08%
October 18, 2021
327,056
11,208
5,417
5.08%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
21:13Now PlayingHIH, Table 2e. Characteristics of Antiviral Agents That Are Approved or Under Evaluation for the Treatment of COVID-19
FDA live
NIH live
Adults: Dosing Regimens
The dose most commonly used in clinical trials is IVM 0.2–0.6 mg/kg PO given as a single dose or as a once-daily dose for up to 5 days.
Adverse events
Generally well tolerated
Dizziness
Pruritis
GI effects (e.g., nausea, diarrhea)
Neurological AEs have been reported when IVM has been used to treat parasitic diseases,
but it is not clear whether these AEs were caused by IVM or the underlying conditions.
Comments and links to clinical trials
Generally given on an empty stomach with water; however, administering IVM with food increases its bioavailability.
A list of clinical trials is available here: Ivermectin
Russia
Deaths,
Independent demographer Alexey Raksha
Using data from Rosstat, Russia’s statistical agency
Excess mortality, around 750,000
Excess mortality, around 660,000
Tracking cases around the world
Officials manipulated statistics and underplayed the crisis
China, Turkey
Alexei Kouprianov, independent analyst and biologist
The data for [Russia] is absolutely unreliable
Recently ex St. Petersburg campus of the Higher School of Economics (September 2020)
Handling of the pandemic, largely left to the regions
Regional officials conceal problems, fear of losing their posts
Therefore critics, even analytical experts, are sidelined
Iceland restricts Moderna
Chief Epidemiologist, Þórólfur Guðnason
Moderna, only be used for booster shots in 60+
Unpublished data from the Nordic countries indicate that the risk of cardiac inflammation after vaccination against COVID-19 is much higher among 18 to 39-year-olds if the Moderna vaccine is used than after vaccination with the Pfizer vaccine
Cardiac inflammation after vaccination is much less common among older demographics
In 12 to 17-year-olds, lack of European data
Under 60 who have received a single shot of Modern, to complete their vaccination with Pfizer
Men 18-39 are not recommended to accept the Moderna COVID-19 vaccine
Iceland data, vast majority of vaccination side effects emerge shortly after vaccination
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
